Curcumin and colorectal cancer: An update and current perspective on this natural medicine

W Weng, A Goel - Seminars in cancer biology, 2022 - Elsevier
Colorectal cancer (CRC) is one of most common malignancies worldwide and its incidence
is still growing. In spite of recent advances in targeted therapies, their clinical efficacy has …

Curcumin and colorectal cancer: An update and current perspective on this natural medicine.

W Weng, A Goel - Seminars in Cancer Biology, 2020 - europepmc.org
Colorectal cancer (CRC) is one of most common malignancies worldwide and its incidence
is still growing. In spite of recent advances in targeted therapies, their clinical efficacy has …

[HTML][HTML] Curcumin and Colorectal Cancer: An Update and Current Perspective On This Natural Medicine

W Weng, A Goel - Seminars in cancer biology, 2022 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of most common malignancies worldwide and its incidence
is still growing. In spite of recent advances in targeted therapies, their clinical efficacy has …

Curcumin and colorectal cancer: An update and current perspective on this natural medicine

W Weng, A Goel - Seminars in cancer biology, 2022 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of most common malignancies worldwide and its incidence
is still growing. In spite of recent advances in targeted therapies, their clinical efficacy has …

[引用][C] Curcumin and colorectal cancer: An update and current perspective on this natural medicine

W Weng, A Goel - Seminars in Cancer Biology, 2022 - cir.nii.ac.jp
Curcumin and colorectal cancer: An update and current perspective on this natural medicine |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Curcumin and colorectal cancer: An update and current perspective on this natural medicine.

W Weng, A Goel - Seminars in Cancer Biology, 2020 - europepmc.org
Colorectal cancer (CRC) is one of most common malignancies worldwide and its incidence
is still growing. In spite of recent advances in targeted therapies, their clinical efficacy has …